Join
Live feed
·
INSIDERFilingvia Quantisnow
Angion Biomedica Corp. logo

SEC Form 4: Rhodes Jennifer J sold $1,090 worth of shares (451 units at $2.42) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 30,399 units to satisfy tax liability

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ANGN (Angion Biomedica Corp.) and more on Quantisnow.